Intratumoral Microdosing of Motolimod in HNSCC
Clinical trial NCT04272333 · TERMINATED
Trial details
- NCT number
- NCT04272333
- Sponsor
- Presage Biosciences
- Status
- TERMINATED
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-10-15
- Primary completion
- 2022-03-25
- Enrollment
- 1
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.